Validity and Reliability of ICIQ-FLUTS LF in Thai Version and Correlation With IPSS
Validity and Reliability of the Translated International Consultation on Incontinence Questionnaire - Female Lower Urinary Tract Symptoms Long Form (ICIQ-FLUTS-LF) in Thai Version and Correlation With the IPSS
1 other identifier
observational
130
1 country
1
Brief Summary
The investigators recruited participants, who were female with LUTS 50 participants for known group validity and 80 normal control females to evaluate for construct validity and test for reliability by statistical analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2024
CompletedFirst Submitted
Initial submission to the registry
February 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedFebruary 21, 2024
February 1, 2024
10 months
February 5, 2024
February 13, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
How well the ICIQ-FLUTS LF questionnaire in the Thai version can differentiate between females with LUTS and normal females, was assessed by the construction validity.
Incontinence Questionnaire - Female Lower Urinary Tract Symptoms Long Form (ICIQ-FLUTS-LF) was divided into 6 subgroups of symptoms measurement, which were storage, voiding, incontinence, bladder pain, post micturition, and ability to stop voiding. The construct validity was determined by comparing the ICIQ-FLUTS LF scores of the target group with the ICIQ-FLUTS LF scores of the control group. The comparisons were performed using the Wilcoxon signed-rank test.
10-12 months
The correlation between items within a subscale of the ICIQ-FLUTS LF questionnaire assessed by internal consistency.
The internal consistency (a parameter that verifies correlations between items within a subscale of the questionnaire) was assessed by using Cronbach's alpha coefficients. The assessment was done in each subscale of the questionnaire. If Cronbach's alpha coefficients were between 0.7 and 0.95, the instrument was considered to have good internal consistency.
10-12 months
The consistency of the repeated measurements by the Thai version of the ICIQ-FLUTS LF was assessed by the test-retest reliability.
The test-retest reliability (a property of producing repeated measurements that are consistent) was verified by having the participants of the target group answer the questionnaire twice with an interval of 2 weeks between the evaluations. We calculated test-retest reliability by using weighted kappa (κ).
10-12 months
Secondary Outcomes (1)
The correlation between the IPSS questionnaire and ICIQ-FLUTS LF questionnaire was assessed by convergent validity.
10-12 months
Study Arms (2)
Female with LUTS
Females who has symptoms of lower urinary tract symptoms
Normal control group
Females who no history of LUTS or urinary tract disease
Interventions
The questionnaire to assess severity of LUTS in women.
Eligibility Criteria
Females with lower urinary tract symptoms who can read and understand Thai language.
You may qualify if:
- age at or over 18 years old
- can read and understand Thai language
- have lower urinary tract symptoms
You may not qualify if:
- those who have a diagnosis of calculi, urinary tract cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thammasat University Hospital
Khlong Luang, Changwat Pathum Thani, 12120, Thailand
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valeerat Swatesutipun, MD
Thammasat University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
February 5, 2024
First Posted
February 21, 2024
Study Start
February 24, 2023
Primary Completion
December 31, 2023
Study Completion
January 20, 2024
Last Updated
February 21, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share